Shanghai Yizhong Pharmaceutical Dividends and Buybacks
Dividend criteria checks 1/6
Shanghai Yizhong Pharmaceutical is a dividend paying company with a current yield of 0.52% that is well covered by earnings.
Key information
0.5%
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.238 |
Payout ratio | 75% |
Recent dividend and buyback updates
Recent updates
Subdued Growth No Barrier To Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) With Shares Advancing 27%
Nov 20We Think You Can Look Beyond Shanghai Yizhong Pharmaceutical's (SHSE:688091) Lackluster Earnings
Nov 08There's Reason For Concern Over Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Massive 34% Price Jump
Oct 01Is Shanghai Yizhong Pharmaceutical (SHSE:688091) Using Too Much Debt?
Aug 20What Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) P/E Is Not Telling You
Jul 24Concerns Surrounding Shanghai Yizhong Pharmaceutical's (SHSE:688091) Performance
Apr 15Getting In Cheap On Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) Is Unlikely
Mar 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 688091 has been paying a dividend for less than 10 years.
Growing Dividend: 688091's dividend payments have increased, but the company has only paid a dividend for 2 years.
Dividend Yield vs Market
Shanghai Yizhong Pharmaceutical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (688091) | 0.5% |
Market Bottom 25% (CN) | 0.5% |
Market Top 25% (CN) | 2.1% |
Industry Average (Pharmaceuticals) | 1.7% |
Analyst forecast (688091) (up to 3 years) | n/a |
Notable Dividend: 688091's dividend (0.52%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.54%).
High Dividend: 688091's dividend (0.52%) is low compared to the top 25% of dividend payers in the CN market (2.12%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (74.7%), 688091's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 688091 is paying a dividend but the company has no free cash flows.